Search

Your search keyword '"van Montfort, Kees"' showing total 6 results
Start Over Author "van Montfort, Kees" Journal blood
6 results on '"van Montfort, Kees"'

2. Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)

Author

Ossenkoppele, Gert J., Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J., Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E., Halkes, C. J.M., Hoogendoorn, Mels, Hollestein, Rene M., Jongen-Lavrencic, Mojca, Levin, Mark D., van de Loosdrecht, Arjan A., van Marwijk Kooij, Marinus, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C., Vellenga, Edo, Verhoef, Gregor E.G., de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R., and Löwenberg, Bob

Published
2012
Full Text
View/download PDF

3. Prognostic Significance of the French-American-British (FAB) Morphologic Subclassification of “Acute Myeloid Leukemia, Not Otherwise Specified” in the 2008 WHO Classification: Analysis of 5,848 Newly Diagnosed Patients From HOVON, MRC/NCRI, SWOG, and MD Anderson Cancer Center

Author

Walter, Roland B., primary, Othus, Megan, additional, Burnett, Alan K., additional, Löwenberg, Bob, additional, Kantarjian, Hagop M., additional, Ossenkoppele, Gert J., additional, Hills, Robert K., additional, van Montfort, Kees G.M., additional, Ravandi, Farhad, additional, Evans, Anna, additional, Pierce, Sherry A., additional, Appelbaum, Frederick R., additional, and Estey, Elihu H., additional

Published
2012
Full Text
View/download PDF

4. Treatment of Secondary Central Nervous System Lymphoma with Intrathecal Rituximab, High Dose Methotrexate and R-DHAP, Followed by Autologous Stem Cell Transplantation. A Phase II HOVON Study

Author

Doorduyn, Jeanette K, primary, van Imhoff, Gustaaf W, additional, van Montfort, Kees CAGM, additional, Schouten, Harry C, additional, Schaafsma, Martyn Ronald, additional, Baars, Johanna W., additional, Kersten, Marie Jose, additional, Lugtenburg, Elly, additional, van den Bent, Martin M.J., additional, Enting, Roelien, additional, Poortmans, Philip M.P., additional, and Bromberg, Jacoline J.E.C., additional

Published
2012
Full Text
View/download PDF

5. Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Author

Cornelissen, Jan J, primary, Gratwohl, Alois, additional, van Montfort, Kees GM, additional, Pabst, Thomas, additional, Maertens, Johan, additional, Beverloo, H. Berna, additional, van Marwijk Kooy, Marinus, additional, Wijermans, P.W., additional, Biemond, Bart J, additional, Breems, Dimitri A., additional, Vellenga, Edo, additional, Verdonck, Leo F, additional, Fey, Martin F., additional, Lavrencic, Mojca, additional, Janssen, Jeroen JWM, additional, Huls, Gerwin, additional, Kuball, Jurgen, additional, Passweg, Jakob R., additional, Graux, Carlos, additional, Schouten, Harry C., additional, Ossenkoppele, Gert, additional, and Lowenberg, Bob, additional

Published
2011
Full Text
View/download PDF

6. Prognostic Significance of the French-American-British (FAB) Morphologic Subclassification of “Acute Myeloid Leukemia, Not Otherwise Specified”in the 2008 WHO Classification: Analysis of 5,848 Newly Diagnosed Patients From HOVON, MRC/NCRI, SWOG, and MD Anderson Cancer Center

Author

Walter, Roland B., Othus, Megan, Burnett, Alan K., Löwenberg, Bob, Kantarjian, Hagop M., Ossenkoppele, Gert J., Hills, Robert K., van Montfort, Kees G.M., Ravandi, Farhad, Evans, Anna, Pierce, Sherry A., Appelbaum, Frederick R., and Estey, Elihu H.

Abstract

Abstract 540This icon denotes a clinically relevant abstract

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results